Masimo | MASI - Gross Profit On Sales

Stock Price
139.19
Daily Change
3.86 2.85%
Monthly
1.54%
Yearly
-20.99%
Q1 Forecast
133.10

Masimo reported $230.6M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
AtriCure USD 101.33M 150K Sep/2025
Avanos Medical USD 86M 6.1M Sep/2025
Baxter International USD 950M 194M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
Dexcom USD 688.8M 99.8M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
General Electric Aerospace USD 3.8B 118M Dec/2025
Globus Medical USD 486.67M 725.06M Sep/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Insulet USD 510.1M 57.9M Sep/2025
Integra LifeSciences USD 206.99M 2.34M Sep/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
Masimo USD 230.6M 2.7M Sep/2025
Medtronic USD 5.44B 123M Sep/2025
Owens Minor USD 526.01M 53.75M Mar/2025
ResMed USD 878.72M 57.9M Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Tandem Diabetes Care USD 134.29M 8.44M Sep/2025
Teleflex USD 451.64M 20.56M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025